CP and melanoma: Tyrosinase activity and, expectedly, content of melanin were significantly increased in B16 cells upon the treatment with [CP(Npx)2] or SBA-15|[CP(Npx)2], indicating terminal differentiation of melanoma cells towards the original melanocyte phenotype (Figure 4A,B).